Feasibility of home administration of nebulised interferon ß-1a (SNG001) for COVID-19: a remote study by Nick A Francis, Phillip D Monk, Jacqueline Nuttall, Thomas Oliver, Catherine Simpson, Jody L Brookes, Victoria J Tear, Angela G Thompson, Toby N Batten, Marcin Mankowski, Thomas MA Wilkinson

Get full text

Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD by Phillip D. Monk, Jody L. Brookes, Victoria J. Tear, Toby N. Batten, Clare Newall, Marcin Mankowski, Michael G. Crooks, Dave Singh, Rekha Chaudhuri, Brian Leaker, Kerry Lunn, Sophie Reynolds, Sarah Dudley, Felicity J. Gabbay, Stephen T. Holgate, Ratko Djukanovic, Thomas MA Wilkinson

Get full text

Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2 by Joseph A. Bell, Elizabeth R. Davies, Christopher J. Brereton, Milica Vukmirovic, James J.W. Roberts, Kerry Lunn, Leanne Wickens, Franco Conforti, Robert A. Ridley, Jessica Ceccato, Lucy N. Sayer, David A. Johnston, Andres F. Vallejo, Aiman Alzetani, Sanjay Jogai, Ben G. Marshall, Aurelie Fabre, Luca Richeldi, Phillip D. Monk, Paul Skipp, Naftali Kaminski, Emily Offer, Yihua Wang, Donna E. Davies, Mark G. Jones

Get full text